NCT03038425

Does Continuous Adductor Canal Nerve Block Improve the Quality of Recovery for Outpatient Total Knee Arthroplasty Patients?

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 81 (actual)
• Sponsor: Ottawa Hospital Research Institute · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This is a randomized, double-blinded pilot study to determine whether patients undergoing ambulatory total knee arthroplasty (TKA) using a subvastus approach benefit from the addition of a continuous adductor canal nerve block (cACB) catheter along with an existing multimodal approach to postoperative analgesia. Outcomes include the 15-item Quality of Recovery Scale (QoR-15) (Miles 2016), pain scores, opioid consumption, opioid-free days, functional outcome as measured by the Time Up and Go (TUG) test, patient satisfaction, patient's rating of catheter effectiveness, and complications.

Conditions

• Arthroplasty, Replacement, Knee
• Nerve Block
• Anesthesia, Regional
• Ambulatory Surgical Procedures

Interventions

Type	Name	Description
DRUG	Normal Saline	This is the placebo intervention - normal saline infused in the adductor canal via a catheter. There are no anticipated therapeutic effect
DRUG	Ropivacaine	This is the treatment intervention - ropivacaine 0.2% infused in the adductor canal via a catheter. This will provide analgesia to the knee after TKA

Timeline

• Start date: 2017-05-02
• Primary completion: 2020-04-01
• Completion: 2020-04-01
• First posted: 2017-01-31
• Last updated: 2020-12-22

Locations

1 site across 1 country: Canada